Diagnostic utility of snail in metaplastic breast carcinoma

Diagnostic Pathology

Volumn 5, Issue 1, 2010, Pages

  Nassar, Aziza ^a   Sookhan, Nicole ^b   Santisteban, Marta ^c   Bryant, Sandra C ^a   Boughey, Judy C ^a   Giorgadze, Tamar ^d   Degnim, Amy ^a  

^a MAYO CLINIC   (United States)

^b St Mary's Health System   (United States)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

^d HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HER2 PROTEIN, HUMAN; KERATIN; OSCAR PROTEIN, HUMAN; PROGESTERONE RECEPTOR; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST TUMOR; CANCER STAGING; CARCINOMA; CASE CONTROL STUDY; CHEMISTRY; DISEASE FREE SURVIVAL; EVALUATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MALE; METAPLASIA; MIDDLE AGED; MORTALITY; PATHOLOGY; PREDICTIVE VALUE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TIME; TREATMENT OUTCOME; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA; CASE-CONTROL STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KERATINS; MALE; METAPLASIA; MIDDLE AGED; MINNESOTA; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTORS, CELL SURFACE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TRANSCRIPTION FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 78649327382     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-5-76     Document Type: Article

References (42)

1. Luini A, Aguilar M, Gatti G, Fasani R, Botteri E, Brito JA, Maisonneuve P, Vento AR, Viale G. Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literature. Breast Cancer Res Treat 2007, 101:349-353. 10.1007/s10549-006-9301-1, 17009109.
2. Günhan-Bilgen I, Memis A, Ustun EE, Zekioglu O, Ozdemir N. Metaplastic carcinoma of the breast: clinical, mammographic, and sonographic findings with histopathologic correlation. AJR 2002, 178:1421-1425.
3. Park JM, Han BK, Moon WK, Choe YH, Ahn SH, Gong G. Metaplastic carcinoma of the breast: mammographic and sonographic findings. J Clin Ultrasound 2000, 28:179-186. 10.1002/(SICI)1097-0096(200005)28:4<179::AID-JCU5>3.0.CO;2-Y, 10751739.
4. Lien HC, Hsiao YH, Lin YS, Yao YT, Juan HF, Kuo WH, Hung MC, Chang KJ, Hsieh FJ. Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: identification of genes potentially related to epithelial-mesenchymal transition. Oncogene 2007, 26(57):7859-71. 10.1038/sj.onc.1210593, 17603561.
5. Knutson KL, Lu H, Stone B, Reiman JM, Behrens MD, Prosperi CM, Gad EA, Smorlesi A, Disis ML. Immunoediting of cancers may lead to epithelial to mesenchymal transition. J Immunol 2006, 177(3):1526-33.
6. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brishen C, Yang J, Weinberg RA. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133(4):704-15. 10.1016/j.cell.2008.03.027, 2728032, 18485877.
7. Santisteban M, Reiman JM, Asiedu MK, Behrens MD, Nassar A, Kalli KR, Haluska P, Ingle JN, Hartmann LC, Manjili MH, Radisky DC, Ferrone S, Knutson KL. Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells. Cancer Res 2009, 69(7):2887-95. 10.1158/0008-5472.CAN-08-3343, 2664865, 19276366.
8. Moody SE, Perez D, Pan TC, Sarkisian CJ, Portocarrero CP, Sterner CJ, Notorfrancesco KL, Cardiff RD, Chodosh LA. The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 2005, 8(3):197-209. 10.1016/j.ccr.2005.07.009, 16169465.
9. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F, Nieto MA. The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000, 2(2):76-83. 10.1038/35000025, 10655586.
10. Zhou BP, Hung MC. Wnt, hedgehog and Snail: sister pathways that control by GSK-3beta and beta-Trcp in the regulation of metastasis. Cell Cycle 2005, 4(6):772-6. 10.4161/cc.4.6.1744, 15917668.
11. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lǿnning PE, Bǿrresen-Dale AL, Brown PO, Botstein D. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001, 98(19):10869-74. 10.1073/pnas.191367098, 58566, 11553815.
12. van't Veer LJ, Paik S, Hayes DF. Gene expression profiling of breast cancer: a new tumor marker. J Clin Oncol 2005, 23(8):1631-5. 10.1200/JCO.2005.12.005, 15755970.
13. Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F, Talantov D, Timmermans M, Meijer-van Gelder ME, Yu J, Jutkoe T, Berns EM, Atkins D, Foekens JA. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005, 365(9460):671-9.
14. Fujita N, Jaye DL, Kajita M, Geigerman C, Moreno CS, Wade PA. MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 2003, 113(2):207-19. 10.1016/S0092-8674(03)00234-4, 12705869.
15. Dunne B, Lee AH, Pinder SE, Bell JA, Ellis IO. An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast. Hum Pathol 2003, 34:1009-1015. 10.1053/S0046-8177(03)00414-3, 14608534.
16. Wargotz ES, Deos PH, Norris HJ. Metaplastic carcinomas of the breast. II. Spindle cell carcinoma. Hum Pathol 1989, 20:732-740. 10.1016/0046-8177(89)90065-8, 2473024.
17. Wargotz ES, Norris HJ. Metaplastic carcinomas of the breast. I. Matrix-producing carcinoma. Hum Pathol 1989, 20:628-635. 10.1016/0046-8177(89)90149-4, 2544506.
18. Wargotz ES, Norris HJ. Metaplastic carcinomas of the breast. III. Carcinosarcoma. Cancer 1989, 64:1490-1499. 10.1002/1097-0142(19891001)64:7<1490::AID-CNCR2820640722>3.0.CO;2-L, 2776108.
19. Wargotz ES, Norris HJ. Metaplastic carcinomas of the breast. IV. Squamous cell carcinoma of ductal origin. Cancer 1990, 65:272-276. 10.1002/1097-0142(19900115)65:2<272::AID-CNCR2820650215>3.0.CO;2-6, 2153044.
20. Blanco MJ, Moreno-Bueno G, Sarrio D, Locascio A, Cano A, Palacios J, Nieto MA. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene 2002, 21(20):3241-6. 10.1038/sj.onc.1205416, 12082640.
21. Rosen PP, Ernsberger D. Low-grade adenosquamous carcinoma. A variant of metaplastic mammary carcinoma. Am J Surg Pathol 1987, 11:351-358. 10.1097/00000478-198705000-00003, 3578645.
22. Sneige N, Yaziji H, Mandavilli SR, Perez ER, Ordonez NG, Gown AM, Ayala A. Low-grade (fibromatosis-like) spindle cell carcinoma of the breast. Am J of Surg Pathol 2001, 25:1009-1016.
23. Brogi E. Benign and malignant spindle cell lesions of the breast. Semin Diagn Pathol 2004, 21:57-64. 10.1053/j.semdp.2003.10.007, 15074560.
24. Dave G, Cosmatos H, Do T, Lodin K, Varshney D. Metaplastic carcinoma of the breast: a retrospective review. Int J Radiat Oncol Biol Phys 2006, 64:771-775. 10.1016/j.ijrobp.2005.08.024, 16246496.
25. Downs-Kelly E, Nayeemuddin KM, Albarracin C, Wu Y, Hunt KK, Gilcrease MZ. Matrix-producing Carcinoma of the Breast: An Aggressive Subtype of Metaplastic Carcinoma. Am J Surg Pathol 2009, 33(4):534-41. 10.1097/PAS.0b013e31818ab26e, 19047898.
26. Hennessy BT, Giordano S, Broglio K, Duan Z, Trent J, Buchholz TA, Babiera G, Hortobagyi GN, Valero V. Biphasic metaplastic sarcomatoid carcinoma of the breast. Ann Oncol 2006, 17:605-613. 10.1093/annonc/mdl006, 16469754.
27. Carter MR, Hornick JL, Lester S, Fletcher CD. Spindle cell (sarcomatoid) carcinoma of the breast: a clinicopathologic and immunohistochemical analysis of 29 cases. Am J Surg Pathol 2006, 30:300-309.
28. Khan HN, Wyld L, Dunne B, Lee AH, Pinder SE, Evans AJ, Robertson JF. Spindle cell carcinoma of the breast: a case series of a rare histological subtype. Eur J Surg Oncol 2003, 29:600-603. 10.1016/S0748-7983(03)00107-0, 12943626.
29. Al Sayed AD, El Weshi AN, Tulbah AM, Rahal MM, Ezzat AA. Metaplastic carcinoma of the breast clinical presentation, treatment results and prognostic factors. Acta Oncol (Stockholm, Sweden) 2006, 45:188-195.
30. Chao TC, Wang CS, Chen SC, Chen MF. Metaplastic carcinomas of the breast. J Surg Oncol 1999, 71:220-225. 10.1002/(SICI)1096-9098(199908)71:4<220::AID-JSO3>3.0.CO;2-L, 10440759.
31. Gibson GR, Qian D, Ku JK, Lai LL. Metaplastic breast cancer: clinical features and outcomes. Am Surg 2005, 71:725-730.
32. Kurian KM, Al-Nafussi A. Sarcomatoid/metaplastic carcinoma of the breast: a clinicopathological study of 12 cases. Histopathology 2002, 40:58-64. 10.1046/j.1365-2559.2002.01319.x, 11903598.
33. Gilbert JA, Goetz MP, Reynolds CA, Ingle JN, Giordano KF, Suman VJ, Blair HE, Jenkins RB, Lingle WL, Reinholz MM, Adjei AA, Ames MM. Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomy. Mol Cancer Ther 2008, 7:944-951. 10.1158/1535-7163.MCT-07-0570, 2745608, 18413808.
34. Gobbi H, Simpson JF, Jensen RA, Olson SJ, Page DL. Metaplastic spindle cell breast tumors arising within papillomas, complex sclerosing lesions, and nipple adenomas. Mod Pathol 2003, 16:893-901. 10.1097/01.MP.0000085027.75201.B5, 13679453.
35. Denley H, Pinder SE, Tan PH, Sim CS, Brown R, Barker T, Gearty J, Elston CW, Ellis IO. Metaplastic carcinoma of the breast arising within complex sclerosing lesion: a report of five cases. Histopathology 2000, 36:203-209. 10.1046/j.1365-2559.2000.00849.x, 10692021.
36. Tse GM, Tan PH, Lui PC, Putti TC. Spindle cell lesions of the breast--the pathologic differential diagnosis. Breast Cancer Res Treat 2008, 109:199-207. 10.1007/s10549-007-9652-2, 17636400.
37. Reis-Filho JS, Milanezi F, Paredes J, Silva P, Pereira EM, Maeda SA, de Carvalho LV, Schmitt FC. Novel and Classic Myoepithelial/Stem Cell Markers in Metaplastic Carcinomas of the Breast. Appl Immunohistochem Mol Morphol 2003, 11:1-8. 10.1097/00022744-200303000-00001, 12610349.
38. Popnikolov NK, Ayala AG, Graves K, Gatalica Z. Benign Myoepithelial Tumors of the Breast Have Immunophenotype Characteristics Similar to Metaplastic Matrix Producing and Spindle Cell Carcinomas. Am J Clin Pathol 2003, 120:161-167. 10.1309/G6CTR8MDTFUW19XV, 12931544.
39. Koker MM, Kleer CG. P63 expression in Breast Cancer. A Highly Sensitive and Specific Marker of Metaplastic Carcinoma. Am J Surg Pathol 2004, 28:1506-15122. 10.1097/01.pas.0000138183.97366.fd, 15489655.
40. Leibl S, Sommersacher A, Denk H, Moinfar F. Metaplastic Breast Carcinomas: Are they of Myoepithelial Differentiation? Immunohistochemical Profile of the Sarcomatoid Subtype Using Novel Myoepithelial Markers. Am J Surg Pathol 2005, 29:347-353. 10.1097/01.pas.0000152133.60278.d2, 15725803.
41. Tse GM, Tan PH, Chaiwun B, Putti TC, Lui PC, Tsang AK, Wong FC, Lo AW. p63 is useful in the diagnosis of mammary metaplastic carcinomas. Pathology 2006, 38:16-20. 10.1080/00313020500444625, 16484002.
42. Sitterding SM, Wiseman WR, Schiller CL, Luan C, Chen F, Moyano JV, Watkin WG, Wiley EL, Cryns VL, Diaz LK. Alpha B-crystallin: a novel marker of invasive basal-like and metaplastic breast carcinomas. Ann Diagn Pathol 2008, 12:33-40. 10.1016/j.anndiagpath.2007.02.004, 18164413.